NCT04028817

Sublingual Photobiomodulation in Parkinson's Disease

Evaluation of the Concentrations of Inflammatory, Protein and Oxidative Biomarkers of Parkinson's Disease After Photobiomodulation From Sublingual Laser Application - Clinical, Randomized and Blind Test

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 40 (estimated)
• Sponsor: University of Nove de Julho · Academic / Other
• Sex: All
• Age: 40 Years
• Healthy volunteers: Not accepted

Summary

This study evaluates the use of photobiomodulation in the treatment of patients with Parkinson's disease. Half of participants will receive treatment with low level laser therapy and exercises in combination, while the other half will receive a placebo laser combined with exercises.

Conditions

• Parkinson Disease

Interventions

Type	Name	Description
DEVICE	photobiomodulation	the intervention will occur twice a week, 18 sessions will be performed, during the sessions will be applied sublingual laser in a single point, with wavelength of 808 nm, diameter of 0.4 cm, with irradiance of 0.8 w / cm2, for 360 s, the laser applied will be of continuous wave with energy of 36J.
DEVICE	placebo photobiomodulation	the intervention will occur twice a week, 18 sessions will be performed, during the sessions will be applied a placebo sublingual laser for 360 s.

Timeline

• Start date: 2020-09-10
• Primary completion: 2021-08-10
• Completion: 2021-12-30
• First posted: 2019-07-23
• Last updated: 2020-06-12

Locations

1 site across 1 country: Brazil